Skip to content
ppharmaranks
Menu

DEPO-SUBQ PROVERA 104 vs RESNIBEN

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. DEPO-SUBQ PROVERA 104 and RESNIBEN are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

64/100
70/100

Pharmacy pays

~$562.79 /30

Type

RX
RX

Active ingredient

MEDROXYPROGESTERONE ACETATE
CABOZANTINIB

Manufacturer

Dosage forms

Injectable
Tablet

Drug class

Progestin

Boxed warning

Treats

Amenorrhea, Breast Neoplasms, Renal Cell Carcinoma
Renal Cell Carcinoma

Frequently asked questions

Which is better-rated, Depo-Subq Provera 104 or Resniben?

By our independent rating, Resniben scores higher — 3.5 vs 3.2 out of 5 for Depo-Subq Provera 104. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Depo-Subq Provera 104 and Resniben?

Depo-Subq Provera 104 contains Medroxyprogesterone Acetate, while Resniben contains Cabozantinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.